News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
46,483 Results
Type
Article (1865)
Company Profile (27)
Press Release (44590)
Multimedia
Podcasts (2)
Webinars (2)
Section
Business (11900)
Career Advice (69)
Deals (1998)
Drug Delivery (3)
Drug Development (6315)
Employer Resources (3)
FDA (1004)
Job Trends (901)
News (20664)
Policy (1506)
Tag
Academia (197)
Accelerated approval (4)
Adcomms (5)
Allergies (12)
Alliances (2699)
ALS (7)
Alzheimer's disease (134)
Antibody-drug conjugate (ADC) (29)
Approvals (1028)
Artificial intelligence (16)
Autoimmune disease (8)
Automation (2)
Bankruptcy (15)
Best Places to Work (756)
BIOSECURE Act (5)
Biosimilars (4)
Biotechnology (18)
Bladder cancer (11)
Brain cancer (7)
Breast cancer (37)
Cancer (339)
Cardiovascular disease (32)
Career advice (54)
Career pathing (1)
CAR-T (36)
CDC (1)
Cell therapy (97)
Cervical cancer (1)
Clinical research (5370)
Collaboration (93)
Compensation (35)
Complete response letters (5)
COVID-19 (206)
CRISPR (8)
C-suite (70)
Cystic fibrosis (11)
Data (508)
Depression (1)
Diabetes (37)
Diagnostics (359)
Digital health (1)
Drug discovery (12)
Drug pricing (3)
Duchenne muscular dystrophy (3)
Earnings (5020)
Editorial (3)
Employer resources (3)
Events (8887)
Executive appointments (83)
FDA (1212)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (102)
Gene editing (16)
Gene therapy (76)
GLP-1 (62)
Government (180)
Guidances (21)
Healthcare (1350)
HIV (7)
IgA nephropathy (6)
Immunology and inflammation (17)
Immuno-oncology (5)
Infectious disease (217)
Inflammatory bowel disease (20)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (13)
Interviews (9)
IPO (1182)
IRA (1)
Job creations (180)
Job search strategy (52)
JPM (5)
Kidney cancer (1)
Labor market (5)
Layoffs (23)
Legal (258)
Liver cancer (9)
Lung cancer (51)
Lymphoma (40)
Machine learning (2)
Management (1)
Manufacturing (41)
MASH (3)
Medical device (669)
Medtech (670)
Mergers & acquisitions (869)
Metabolic disorders (65)
Multiple sclerosis (11)
Neurodegenerative disease (22)
Neuropsychiatric disorders (1)
Neuroscience (180)
NextGen: Class of 2026 (452)
Non-profit (303)
Now hiring (2)
Obesity (27)
Opinion (3)
Ovarian cancer (6)
Pain (12)
Pancreatic cancer (16)
Parkinson's disease (10)
Patents (24)
Patient recruitment (33)
Peanut (4)
People (3858)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (1824)
Phase 2 (2314)
Phase 3 (1910)
Pipeline (348)
Policy (16)
Postmarket research (224)
Preclinical (614)
Press Release (3)
Prostate cancer (13)
Psychedelics (1)
Radiopharmaceuticals (13)
Rare diseases (65)
Real estate (356)
Recruiting (2)
Regulatory (1344)
Reports (8)
Research institute (158)
Resumes & cover letters (6)
RSV (2)
Schizophrenia (6)
Series A (18)
Series B (8)
Service/supplier (2)
Sickle cell disease (6)
Special edition (2)
Spinal muscular atrophy (6)
Sponsored (6)
Startups (218)
Supply chain (3)
Tariffs (2)
The Weekly (2)
Vaccines (43)
Venture capital (5)
Weight loss (11)
Women's health (2)
Worklife (1)
Date
Last 7 days (40)
Last 30 days (112)
Last 365 days (1957)
2026 (172)
2025 (2129)
2024 (2723)
2023 (3079)
2022 (4383)
2021 (5195)
2020 (4403)
2019 (3390)
2018 (2229)
2017 (2015)
2016 (1838)
2015 (2122)
2014 (1373)
2013 (1179)
2012 (1253)
2011 (1384)
2010 (1215)
Location
Africa (29)
Arizona (9)
Asia (2663)
Australia (447)
California (848)
Canada (278)
China (89)
Colorado (38)
Connecticut (25)
Delaware (41)
Europe (7429)
Florida (89)
Georgia (9)
Idaho (1)
Illinois (34)
India (10)
Indiana (12)
Iowa (1)
Japan (53)
Kansas (4)
Kentucky (2)
Maryland (102)
Massachusetts (453)
Michigan (13)
Minnesota (62)
Mississippi (1)
Missouri (85)
Nevada (15)
New Hampshire (7)
New Jersey (167)
New Mexico (1)
New York (127)
North Carolina (95)
Northern California (400)
Ohio (8)
Oklahoma (1)
Oregon (2)
Pennsylvania (182)
Puerto Rico (2)
Rhode Island (2)
South America (55)
South Carolina (1)
Southern California (312)
Tennessee (11)
Texas (130)
United States (2567)
Utah (12)
Virginia (15)
Washington D.C. (2)
Washington State (40)
Wisconsin (7)
46,483 Results for "1st biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Frédéric Prince to Succeed Christian Loss, Effective January 1st, 2026
January 5, 2026
·
1 min read
Press Releases
Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy
January 12, 2026
·
6 min read
Press Releases
SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
January 12, 2026
·
3 min read
Press Releases
Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa
January 27, 2026
·
5 min read
Press Releases
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
January 29, 2026
·
8 min read
Press Releases
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
February 4, 2026
·
19 min read
Press Releases
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
January 12, 2026
·
7 min read
Press Releases
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
December 3, 2025
·
3 min read
Press Releases
FORE Biotherapeutics to Participate in Upcoming November 2025 Investor Conferences
November 5, 2025
·
1 min read
Press Releases
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
December 8, 2025
·
10 min read
1 of 4,649
Next
